Found: HC 118 4th Use of evaluation and modelling in government HC 254 5th Local economic growth HC 252 6th Department

Found: Pharmaceutical Officer for England Cc: Rt Hon Dame Andrea Leadsom MP, Parliamentary Under-Secretary of State, Department

Found: It is the Department of Health and Social Care. They set the policies.

Found: 37 Eighteenth Report of Session 2023 -24 HM Treasury Excess Votes 2022 -23: The Department of Health

Found: Department for Business and Trade funding relating to local business growth (i.e., for Growth Hubs)  Department

Found: there are any suitable work-related activities an individual can participate in. 41.The DWP and Department

Found: This response includes representatives from the Department of Health and Social Care (DHSC), Border

Found: PRT0081 - Preterm Birth Department of Health and Social Care Written Evidence

Found: Government’s position While t he Department of Health and Social Care has not produced a separate

Found: Yo u stated this would be discussed with the relevant Minister from the Department of Health and Social

Found: For instance, care homes come under the Department of Health and Social Care, but they have employees

Found: There is some suggestion that if you have a health matter, the Department of Health and Social Care

Question to the Department for Levelling Up, Housing & Communities:

To ask the Secretary of State for Levelling Up, Housing and Communities, what recent assessment his Department has made of trends in the level of mould in the (a) owner-occupied, (b) private rented and (c) social rented sector.

Answered by Jacob Young - Parliamentary Under Secretary of State (Department for Levelling Up, Housing and Communities)

As set out in my answer to Question UIN 24168 on 3 May 2024, the English Housing Survey sets out levels of damp and mould in all tenures of residential accommodation. Details are available online.

For more information on the health impacts of damp and mould in homes, please see our consolidated guidance developed with the Department of Health and Social Care. It can be found at https://www.gov.uk/government/publications/damp-and-mould-understanding-and-addressing-the-health-risks-for-rented-housing-providers.

Following the tragic death of the two-year-old Awaab Ishak, due to the appalling housing conditions that Awaab Ishak and his family had to live in, the Secretary of State summoned the leadership of their landlord, Rochdale Boroughwide Housing, to explain why such catastrophic failures had been allowed to happen. The Government has also legislated for ‘Awaab’s law’, introduced via the Social Housing (Regulation) Act 2023.

In his written statement of 9 January 2024 (HCWS174) the Secretary of State launched a consultation on how ‘Awaab’s law’ will operate in practice, including the specific requirements on social landlords. The consultation closed on 5 March 2024 and we are analysing the responses. Once this has been completed, we will bring forward secondary legislation as soon as possible.

The department, last year, provided £15 million of funding to the Greater Manchester Combined Authority to tackle the worst cases of damp and mould. They have now completed improvements to around 4,000 homes.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the contract awarded by her Department to PA Consulting Services Limited on 8 January 2024 under procurement reference CF-2104, what the estimated cost to the public purse will be of the completed work.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many (a) estates and (b) facilities related incidents related to (i) non-critical and (ii) critical infrastructure risk occurred in (A) all hospitals and (B) hospitals containing reinforced autoclaved aerated concrete in the last 12 months.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Home Office:

To ask the Secretary of State for the Home Department, how the UK Border Force are identifying synthetic drugs being imported into the UK; and what steps is he taking to ensure effective monitoring of this.

Answered by Tom Pursglove - Minister of State (Minister for Legal Migration and Delivery)

Tackling illicit drugs, including potent synthetic opioids, is a priority for the Government, and through our 10-year drugs strategy ‘From Harm to Hope’ the Home Office is taking action to tackle drug supply and reduce demand.

Border Force uses intelligence from law enforcement and sources overseas to target action at the border and identify shipments for examination.

The cross-Government Synthetic Opioids Taskforce is working with partners such as the NCA, the Department of Health and Social Care and the National Police Chiefs Council to deliver an evidence-based response to the risk posed by synthetic opioids, monitor the effectiveness of the response, including at the border, and to implement effective action to stem the demand and supply of these dangerous substances.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what contingency planning, if any, they have conducted to anticipate the spread of tropical virus transmission to the United Kingdom.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The outbreak of an emerging infectious disease is a categorised risk, in the 2023 National Risk Register. Working closely with the Department and NHS England, the UK Health Security Agency (UKHSA) has a programme of work in place to plan and respond to this risk.

The UKHSA continues to monitor the global epidemiology of infectious diseases, to inform the assessment of risk to the United Kingdom’s population. Routine surveillance is carried out for a range of viral infections that may be acquired overseas. Data on some of these infections is published in the annual Travel-associated infections reports. Information collated from these various sources are routinely reviewed and assessed through the relevant UKHSA Horizon Scanning Group, with appropriate public health actions proposed to mitigate any threats.

The Rare and Imported Pathogens Laboratory has a small serological study, partnering with NHS Blood and Transplant and at-risk groups, to look for evidence of exposure to Usutu, West Nile, and tick-borne encephalitis viruses. The Medical Entomology and Zoonoses Ecology group study vector distribution, and look for the presence of tropical and other viruses in relevant arthropod species in an ongoing surveillance programme. The Animal and Plant Health Agency has a programme of surveillance in wild birds and mammals. The Department of Health and Social Care, the UKHSA, and the Department for Environment, Food and Rural Affairs published a national contingency plan for invasive mosquitoes that may spread vector-borne diseases, such as dengue, Zika and chikungunya.

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what recent assessment his Department has made of the potential merits of extending the eligibility criteria for Carer’s Allowance to a larger number of unpaid carers; and if she will make an assessment of the potential impact of unpaid care work on the (a) physical and (b) mental health of women.

Answered by Mims Davies - Minister of State (Department for Work and Pensions)

The Government keeps Carer’s Allowance under review to see whether it is meeting its objectives. It has no current plans to extend the eligibility criteria.

Questions on the impact of unpaid care work on individuals are matters for the Department of Health and Social Care in England and for the Devolved Administrations in Scotland, Wales and Northern Ireland.

Carer’s Allowance is a devolved benefit in Scotland.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many people have been waiting more than 12 months for (a) knee and (b) hip replacement surgery in the North East as of 29 April 2024.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department for Environment, Food and Rural Affairs:

To ask His Majesty's Government what assessment they have made of the risk of H5N1 bird flu, following an outbreak in cattle in multiple US states with reports that many cattle are asymptomatic; what monitoring they carry out on (1) cattle, (2) other farm animals, (3) wild mammals, and (4) humans in contact with cattle; and what, if any, additional biosecurity measures are planned or being developed.

Answered by Lord Douglas-Miller - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

The Government is in close contact with counterparts in the United States on the incidents of influenza of avian origin in cattle in the USA. We know that the strain of virus involved has not been detected in the UK.

Defra is working closely with the Department of Health and Social Care (DHSC), the UK Health Security Agency (UKHSA), the Food Standards Agency, the Cabinet Office and with international partners on risk assessments to consider the routes of incursion, animal to animal spread and animal to human spill-over and to review our well-tested surveillance mechanisms and preparedness activities in light of this emerging situation.

In response to the unprecedented global outbreaks of highly pathogenic avian influenza (HPAI) H5N1 in wild and kept birds, the UK's avian influenza national reference laboratory at the Animal and Plant Health Agency Weybridge laboratory has increased its surveillance in both wild birds and wild mammals and genome analysis of the virus itself while keeping a close eye on its spread in global populations of wildlife. In addition, we have published an ‘Influenza A (H5N1) infection in mammals: suspect case definition and diagnostic testing criteria’ on gov.uk to support veterinary professionals and others in knowing when to report suspicion. This case definition will be updated in due course as further information on the emerging situation in cattle in the USA becomes available.

We are monitoring the situation closely but at this time have no reason to suspect the virus is circulating in our cattle, nor is this strain of the virus circulating in Europe. We have had no recent cases of avian influenza in kept birds, or findings of influenza of avian origin in kept or wild mammals, and the risk level from wild birds is low. We have discussed the need for surveillance in wildlife, domestic animals and humans with DHSC and UKHSA and are considering the case for additional surveillance for influenza of avian origin in cattle and how best such animal health surveillance could be undertaken.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the oral contribution by the Parliamentary Under Secretary of State at the Department of Health and Social Care during the debate on Covid-19: Response and Excess Deaths on Thursday 18 April 2024, Official Report, column 537, whether she has had recent discussions with (a) NICE and (b) the MHRA on their progress on reaching a decision on whether to recommend the use of Evusheld 2 to prevent covid-19.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department meets with the National Institute of Health and Care Excellence (NICE) regularly to discuss a range of issues, including access to medicines. The NICE has formally started its appraisal of AZD-3152, also known as sipavibart and referred to as Evusheld 2, ahead of the Medicines and Healthcare products Regulatory Agency’s (MHRA) decision on whether it should be given a United Kingdom marketing authorisation, and expects to invite stakeholder submissions in April 2024. Timelines for both the NICE’s guidance and licensing depend on data from the SUPERNOVA trial being available. AstraZeneca intends to submit clinical data to the NICE and the MHRA at the same time, with the aim that both organisations are able to reach decisions as close together as possible. If AZD-3152 is recommended as clinically and cost effective by the NICE, the National Health Service in England will be under a statutory requirement to fund AZD-3152 for eligible patients, in line with the NICE’s recommendations.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to the statement by the US Centres for Disease Control and Prevention entitled Highly Pathogenic Avian Influenza A (H5N1) Virus Infection Reported in a Person in the US, published on 1 April 2024, what assessment he has made of the level of risk posed by H5N1; and whether he has had discussions with the (a) Secretary of State for Health and Social Care and (b) Deputy Prime Minister and Chancellor of the Duchy of Lancaster on the potential implications for the UK Biological Security Strategy of that statement.

Answered by Mark Spencer - Minister of State (Department for Environment, Food and Rural Affairs)

We are in close contact with counterparts in the United States on the incidents of influenza of avian origin in cattle in the USA. We know that the strain of virus involved has not been detected in the UK.

We are working closely with the Department of Health and Social Care, UK Health Security Agency, Food Standards Agency and Cabinet Office officials and with international partners on risk assessments to consider the routes of incursion, animal to animal spread and animal to human spill-over and to review our well-tested surveillance mechanisms and preparedness activities in light of this emerging situation.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she is taking steps to ensure that family hubs provide advice on smoking and vaping harm reduction.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Smoking is the number one entirely preventable cause of ill-health, disability, and death in this country. It is responsible for 80,000 yearly deaths in the United Kingdom, and one in four of all UK cancer deaths. It costs our country £17 billion a year, £14 billion of which is through lost productivity alone. It puts a huge pressure on the National Health Service and social care, costing over £3 billion a year.

The Government is investing an additional £300 million to improve support for families, though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. The Family Hubs and Start for Life programme guide sets out minimum expectations that local authorities receiving programme funding should deliver by March 2025. With regards to smoking support, the programme guide sets out that staff in a family hub are expected to be trained in delivering Very Brief Advice on smoking to parents identified as smokers, and some family hubs may provide smoking cessation support on-site, for example through drop-ins.

Staff in family hubs know what stop smoking services (SSS) are provided locally, and connect families to these services. Smokers are three times as likely to succeed with SSS, when compared to an unsupported quit attempt. As announced in Stopping the start: our new plan to create a smokefree generation, published in October 2023, the Government is investing an additional £70 million per year, for five years, to support local authority led SSS, almost doubling current spend and supporting 360,000 people to set a quit date each year.

In addition, we are establishing a financial incentives scheme to help pregnant smokers and their partners to quit smoking, with smoking cessation support. This evidence-based intervention will encourage pregnant women to give up smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.

Whilst anyone smoking should focus on giving up cigarettes before giving up vaping, giving up vaping is an important step in overcoming nicotine dependence. We are working with the NHS Better Health website to provide advice for people who want to quit vaping. The National Centre for Smoking Cessation and Training has produced guidance for local SSS staff, on how best to support vapers to quit. We are also exploring further ways to support people to quit vaping, as part of the national Swap to Stop programme.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on commercial aircraft.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.

The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.

An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on trains.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.

The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.

An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what requirements there are for airlines to ensure adrenaline auto-injectors are available on commercial flights.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.

The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.

An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what requirements there are for airports to ensure adrenaline auto-injectors are available on their premises.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.

The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.

An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what guidance they have issued on the administering of adrenaline auto-injectors by minors in medical emergencies.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.

An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what guidance they have issued regarding the use of an adrenaline auto-injector on someone to whom it was not prescribed in a medical emergency.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.

An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether there are telecare devices being sold that will no longer be fully operational after the Public Switched Telephone Network is switched off.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of her policies on health outcomes for children who live in poverty.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.

The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.

The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.

In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:

https://fingertips.phe.org.uk/profile/child-health-profiles

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to tackle health inequality due to childhood poverty.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.

The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.

The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.

In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:

https://fingertips.phe.org.uk/profile/child-health-profiles

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the impact of childhood poverty on longitudinal health outcomes.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.

The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.

The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.

In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:

https://fingertips.phe.org.uk/profile/child-health-profiles

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how she is targeting health prevention services to support children who live in poverty.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.

The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.

The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.

In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:

https://fingertips.phe.org.uk/profile/child-health-profiles

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made an estimate of the cost to the public purse of awarding a pay rise to NHS junior doctors of (a) 5%, (b) 10%, (c) 15%, (d) 20%, (e) 25%, (f) 30% and (g) 35%.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the cost was of the early exit from the lease for the Rosalind Franklin Laboratory.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Found: Impact assessments relating to this instrument have been prepared and copies can be obtained from the Department

Found: Department of Health and Social Care (2024).

Found: The Department of Health and Social Care and NHS England have publishe d guidance on the management

Found: The Smokefree Generation does not 1 Tobacco and Vapes Bill. [ link] 2 Department of Health and

Found: From: Department of Health and Social Care, The Scottish Government, Welsh Government, Department for

Found: of Health and Social Care 356 348 0 8 22 Foreign, Commonwealth and Development Office [note 4] 320 184

Found: of Health and Social Care 1665 1656 0 9 35 1665 1469 117 79 88.22822823 95.25525526 1665 116 532 1017

Found: From: Department of Health and Social Care Published 2 May 2024 Get emails about this page

Found: From: Department of Health and Social Care Published 2 May 2024 Get emails about this page

Found: statutory etc purposes Condition 4 – safeguarding of children and individuals at risk 14.4 The Department

Found: Leads: Department of Health and Social Care, National Institute for Health and Care Research Measure

Found: Leads: Department of Health and Social Care, National Institute for Health and Care Research Measure

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care .

Found: From: Department of Health and Social Care, The Scottish Government, Welsh Government, Department for

Found: regulatory sandbox for AI medical devices in healthcare, is being developed with funding from the Department

Found: The MHRA is an executive agency of the Department of Health and Social Care.

Found: The MHRA is an executive agency of the Department of Health and Social Care.

Found: The MHRA is an executive agency of the Department of Health and Social Care. 

Found: The MHRA is an executive agency of the Department of Health and Social Care. 

Found: The MHRA is an executive agency of the Department of Health and Social Care. 

Found: Nordisk UK in agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) and the Department

Found: Nordisk UK in agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) and the Department

Found: Nordisk UK in agreement with the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Department

Found: The Department of Health and Social Care (DHSC) has confirmed that, as this is a prescription -only

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care (DHSC).

Found: Impact assessments relating to this instrument have been prepared and copies can be obtained from the Department

Found: This response includes representatives from the Department of Health and Social Care (DHSC), Border

Found: Communities delivers a range of trauma-informed and person-centred“[...] the positioning of sport within the Department